Mr. Magomana graduated with an MBA from The University of Illinois at Urbana-Champaign. He holds an MPH in Public Administration and an MA in International Relations. He got his BA from Grinnell College in 2007.
An FDA inspector didn’t have to spend long to discover that a Canadian API maker was failing to meet FDA standards for product testing, not to mention finding insects and spiders in its packaging area The FDA posted a warning letter this week that was sent to Les Produits Chimiques in Pointe-Claire, Québec. The two-observation warning followed a one-day inspection last fall during which it was found that the company was not testing for identity of API powder that had sold into th
1. Medtronic plc $28.8B 2. Johnson & Johnson $25.1B 3. GE Healthcare $18.3B 4. Siemens Healthineers $15.2B 5. Becton Dickinson $12.5B 6. Cardinal Health $12.4B 6. Philips HealthTech $12.4B 8. Stryker $11.3B 9. Baxter $10.2B 10. Abbott Laboratories $10.1B 11. Boston Scientific $8.4B 12. Danaher $7.8B 13. Zimmer Biomet $7.7B 14. Essilor $7.5B 15. B. Braun $6.8B 16. St. Jude Medical $6.
Mr. Trymore Magomana is a Global Business Development Associate for Wipro LTD. He works in their pharma, healthcare and medical devices practice in New York City, New York, United States of America. Mr. Magomana is taking a year-long deferment from a doctoral student position with Tulane University School of Public Health & Tropical Medicine, in their global health division. Mr. Magomana graduated with an MBA from The University of Illinois at Urbana-Champaign specializing in Marketing, St
In March, Johnson & Johnson tapped mobile health tech player Welldoc to incorporate its diabetes management platform into J&J’s latest blood glucose monitor. Now, the pair is announcing FDA clearance of the wireless integration between the two systems.
It's easy to see why EpiPen has become the focus of America's fury over drug prices. It treats potentially deadly allergic reactions — for example, in a child who is stung by a bee — and its price has spiked by over 500% in a few years.
French pharmaceutical company Sanofi Pasteur says it's no longer profitable to make one of the most vital anti-venom for snakebites in Africa.Fav-Afrique counters the toxins of some of the world's most deadly venomous snakes.
It is well documented that the cost of prescription medication is very high in America, higher than any other region in the world. for example, Gilead's Solvadi cost $81 000 to treat Hepatitis C. As a result, patients try to do all they can to minimize the cost of medication. One of the way that patients reduce medication cost is through discounts.
Roche’s Gazyva fell short in a late-stage lymphoma trial, jeopardizing the company’s expansion plans for the Rituxan follow-up. The newer med failed to best gold-standard Rituxan in previously untreated patients with diffuse large B-cell lymphoma, according to topline results from a new trial.
India's drug export industry players such as Sun Pharmaceutical Industries, Dr. Reddy's Laboratories ($DRREDDY) and Glenmark Pharmaceuticals among others took an estimated combined hit of as much as INR5 billion ($75 million) from the sharp fall in the British pound after a U.K. referendum told the country to leave the European Union--in what has become known as "Brexit."
Advertising Age’s annual ranking of the 200 leading national advertisers in the U.S. found that pharma industry spending rose more than any other category, increasing overall by 15.6% last year.
Awwwards site of the day 2013 Awwwards site of the day 2013 Awwwards site of the day 2013 Awwwards site of the day 2013 Awwwards site of the day 2013 Awwwards site of the day 2013